Seizure activity and unresponsiveness after hydroxycut ingestion

Pharmacotherapy

Volumn 21, Issue 5, 2001, Pages 647-651

  Kockler, Denise R ^a   McCarthy, Michelle W ^a   Lawson, Cathy L ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b CVS Caremark   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; CAFFEINE; EPHEDRINE; HERBACEOUS AGENT;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CASE REPORT; DIET SUPPLEMENTATION; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HERBAL MEDICINE; HUMAN; MALE; SEIZURE;

ADULT; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CITRATES; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; EPHEDRA SINICA; EPHEDRINE; HUMANS; MALE; PHYTOTHERAPY; PICOLINIC ACIDS; PLANT PREPARATIONS; POLYSACCHARIDES; SEIZURES; THEOBROMINE; THEOPHYLLINE;

EID: 0035009891     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.21.6.647.34542     Document Type: Article

References (27)

1. Unconventional medicine in the United States, prevalence, costs, and patterns of use
2. Trends in alternative medicine use in the United States, 1990-1997, results of a follow-up national survey
3. White paper on herbal products
4. Safety issues with herbal products
5. Safety issues with herbal medicine
6. Illnesses and injuries associated with the use of selected dietary supplements
7. An FDA guide to dietary supplements
8. Hydroxycut product information
9. The ephedras
10. Adverse events associated with ephedrine-containing products - Texas, December 1993-September 1995
11. Intracerebral hemorrhage and vasculitis related to ephedrine abuse
12. FDA proposes constraints on ephedrine dietary supplements
13. New safety measures are proposed for dietary supplements containing ephedrine alkaloids
14. FDA backs away from elements of plan to regulate ephedrine supplements
15. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids
16. Drugs used in the treatment of asthma
17. Pharmacological rationale for the clinical use of caffeine
18. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes
19. Chromium picolinate toxicity
20. Over-the-counter chromium picolinate
21. Chromium picolinate
22. Inhibition of citrate lyase may aid aerobic endurance
23. Promotion of hepatic lipid oxidation and gluconeogenesis as a strategy for appetite control
24. Carnitor (levocarnitine) package insert
25. History of drugs for thrombotic disease: Discovery, development, and directions for the future
26. Willow bark
27. A method to estimate the probability of adverse drug reactions